PAREXEL is a proven and committed partner to drug developers and medical device manufacturers looking to bring innovative new products to market. Our Phase I-IV studies incorporate the full range of services from clinical study design to bioanalytics to peri-approval and post-marketing services, with an emphasis on First in Man and Proof of Concept studies. We have decades of experience, deep expertise, and the global resources required to handle studies – and programs of studies – of any size, anywhere in the world.

Expertise

No matter what your product goal, we have the key to your success – in today's R&D environment, the key to success is maximizing your product value at every milestone and phase of development, no matter what your ultimate product goal. At PAREXEL we offer an integrated, flexible approach with a unique fusion of expertise. Leveraging our global reach and eClinical technologies we strive to efficiently develop your product with the highest quality, safety and compliance in order to add value and help you reach your goal.

Pharmacovigilance

Safety first, safety always – PAREXEL’s pharmacovigilance experts monitor the safety and efficacy of marketed drugs, and assess their risks and benefits, in line with worldwide regulatory reporting requirements. We help clients avoid costly errors that can threaten revenues and reputation.

More

Investigator Sign Up

Click here to complete a profile.

 

PAREXEL's Bio/Pharmaceutical R&D Statistical Sourcebook 2008/2009

Now Available!
An invaluable resource for executives and managers working within or with the pharmaceutical and biotechnology industries. This 2008/2009 compilation puts real-world data sets and industry insights at your fingertips for presentations, reports, business development efforts, meetings, and critical decision-making analyses.

More Details